LONGEVERON, LLC
MIAMI, FLORIDA

About Longeveron Longeveron is a life sciences company developing biological solutions for aging and aging-associated diseases through the use of Allogeneic Human Mesenchymal Stem Cells, harvested and grown at our facility in Miami, Florida, from adult-donor bone marrow. The Longeveron-grown Mesenchymal Stem Cells (LMSCs) are multipotent stem cells. Longeveron is located in the Life Science & Technology Park (LSTP) in Miami, Florida. Its state-of-the-art manufacturing facilities and production are under FDA oversight and comply with FDA and other regulatory agency requirements. Thus, patients and physicians can be confident that an exceptionally safe and high-quality product is delivered. Founded in 2014, Longeveron is striving to address major, unmet market needs by providing stem cell products that effectively treat aging-related deficits in functional capacity, including Alzheimer’s disease, Frailty and Metabolic Syndrome, which impact millions of people in the U.S. Our novel and proprietary cell production technologies will make available products to healthcare providers for treatment of these currently incurable ailments and are based upon rigorous scientific and medical understanding of the cell therapeutic area. Longeveron-grown Mesenchymal Stem Cells (LMSCs) have already undergone clinical testing with positive safety data results. Additional FDA approved clinical trials are underway as we strive to obtain FDA approval of our cell-based products and continue to demonstrate the safety and efficacy of the products as treatment for a range of conditions. About Longeveron Longeveron is a life-sciences company developing biological solutions for aging and aging-associated diseases. We believe regenerative medicine, through cell-based therapy, is a promising new approach to treating these conditions. Participating in FDA-evaluated clinical trials, we are currently testing our cell-based therapy product for a diagnosable ailment called Aging Frailty, a growing condition impacting approximately 50 million Americans over the age of 60. In addition to Aging Frailty, Longeveron scientists, doctors and the clinical trial team are working together to test the efficacy of our product on Alzheimer’s disease, a dreaded neurological condition that has no cure and Metabolic Syndrome, which affects millions of people, putting them at increased risk for heart disease. All three of these conditions are currently treated using a limited number of therapies, but to-date have no cure. If you are interested in learning more about Longeveron or participating in a trial please fill out the form below or